PURPOSE: To determine whether a low-fat diet high in vegetables, fruit, and fiber differentially affects prognosis in breast cancer survivors with hot flashes (HF) or without HF after treatment. PATIENTS AND METHODS: A secondary analysis was conducted on 2,967 breast cancer survivors, age 18 to 70 years, who were randomly assigned between 1995 and 2000 in a multicenter, controlled trial of a dietary intervention to prevent additional breast cancer events and observed through June 1, 2006. We compared the dietary intervention group with a group who received five-a-day dietary guidelines. RESULTS: Independent of HF status, a substantial between-group difference among those who did and did not receive dietary guidelines was achieved and maintained at 4 years in intake of vegetable/fruit servings per day (54% higher; 10 v 6.5 servings/d, respectively), fiber (31% higher; 25.5 v 19.4 g/d, respectively), and percent energy from fat (14% lower; 26.9% v 31.3%, respectively). Adjusting for tumor characteristics and antiestrogen treatment, HF-negative women assigned to the intervention had 31% fewer events than HF-negative women assigned to the comparison group (hazard ratio [HR] = 0.69; 95% CI, 0.51 to 0.93; P = .02). The intervention did not affect prognosis in the women with baseline HFs. Furthermore, compared with HF-negative women assigned to the comparison group, HF-positive women had significantly fewer events in both the intervention (HR = 0.77; 95% CI, 0.59 to 1.00; P = .05) and comparison groups (HR = 0.65; 95% CI, 0.49 to 0.85; P = .002). CONCLUSION: A diet with higher vegetable, fruit, and fiber and lower fat intakes than the five-a-day diet may reduce risk of additional events in HF-negative breast cancer survivors. This suggestive finding needs confirmation in a trial in which it is the primary hypothesis.
RCT Entities:
PURPOSE: To determine whether a low-fat diet high in vegetables, fruit, and fiber differentially affects prognosis in breast cancer survivors with hot flashes (HF) or without HF after treatment. PATIENTS AND METHODS: A secondary analysis was conducted on 2,967 breast cancer survivors, age 18 to 70 years, who were randomly assigned between 1995 and 2000 in a multicenter, controlled trial of a dietary intervention to prevent additional breast cancer events and observed through June 1, 2006. We compared the dietary intervention group with a group who received five-a-day dietary guidelines. RESULTS: Independent of HF status, a substantial between-group difference among those who did and did not receive dietary guidelines was achieved and maintained at 4 years in intake of vegetable/fruit servings per day (54% higher; 10 v 6.5 servings/d, respectively), fiber (31% higher; 25.5 v 19.4 g/d, respectively), and percent energy from fat (14% lower; 26.9% v 31.3%, respectively). Adjusting for tumor characteristics and antiestrogen treatment, HF-negative women assigned to the intervention had 31% fewer events than HF-negative women assigned to the comparison group (hazard ratio [HR] = 0.69; 95% CI, 0.51 to 0.93; P = .02). The intervention did not affect prognosis in the women with baseline HFs. Furthermore, compared with HF-negative women assigned to the comparison group, HF-positive women had significantly fewer events in both the intervention (HR = 0.77; 95% CI, 0.59 to 1.00; P = .05) and comparison groups (HR = 0.65; 95% CI, 0.49 to 0.85; P = .002). CONCLUSION: A diet with higher vegetable, fruit, and fiber and lower fat intakes than the five-a-day diet may reduce risk of additional events in HF-negative breast cancer survivors. This suggestive finding needs confirmation in a trial in which it is the primary hypothesis.
Authors: Wayne A Bardwell; Jacqueline M Major; Cheryl L Rock; Vicky A Newman; Cynthia A Thomson; Janice A Chilton; Joel E Dimsdale; John P Pierce Journal: Psychooncology Date: 2004-09 Impact factor: 3.894
Authors: Cheryl L Rock; Shirley W Flatt; Cynthia A Thomson; Marcia L Stefanick; Vicky A Newman; Lovell A Jones; Loki Natarajan; Cheryl Ritenbaugh; Kathryn A Hollenbach; John P Pierce; R Jeffrey Chang Journal: J Clin Oncol Date: 2004-06-15 Impact factor: 44.544
Authors: John P Pierce; Vicky A Newman; Shirley W Flatt; Susan Faerber; Cheryl L Rock; Loki Natarajan; Bette J Caan; Ellen B Gold; Kathryn A Hollenbach; Linda Wasserman; Lovell Jones; Cheryl Ritenbaugh; Marcia L Stefanick; Cynthia A Thomson; Sheila Kealey Journal: J Nutr Date: 2004-02 Impact factor: 4.798
Authors: Sandra M Swain; Stephanie R Land; Marcie W Ritter; Joseph P Costantino; Reena S Cecchini; Eleftherios P Mamounas; Norman Wolmark; Patricia A Ganz Journal: Breast Cancer Res Treat Date: 2008-02-27 Impact factor: 4.872
Authors: John P Pierce; Susan Faerber; Fred A Wright; Cheryl L Rock; Vicky Newman; Shirley W Flatt; Sheila Kealey; Vicky E Jones; Bette J Caan; Ellen B Gold; Mary Haan; Kathryn A Hollenbach; Lovell Jones; James R Marshall; Cheryl Ritenbaugh; Marcia L Stefanick; Cynthia Thomson; Linda Wasserman; Loki Natarajan; Ronald G Thomas; Elizabeth A Gilpin Journal: Control Clin Trials Date: 2002-12
Authors: Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith Journal: Cochrane Database Syst Rev Date: 2012-05-16
Authors: Shannon M Christy; Catherine E Mosher; Richard Sloane; Denise C Snyder; David F Lobach; Wendy Demark-Wahnefried Journal: J Am Diet Assoc Date: 2011-12
Authors: Jennifer A Emond; Ruth E Patterson; Loki Natarajan; Gail A Laughlin; Ellen B Gold; John P Pierce Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-03-17 Impact factor: 4.254
Authors: Raheem J Paxton; Lovell A Jones; Shine Chang; Mike Hernandez; Richard A Hajek; Shirley W Flatt; Loki Natarajan; John P Pierce Journal: Cancer Date: 2011-02-11 Impact factor: 6.860
Authors: Brian N Fink; Jeffrey G Weiner; Timothy R Jordan; Amy J Thompson; Timothy C Salvage; Mina Coman; Joyce Balls-Berry Journal: Breast Cancer (Auckl) Date: 2010-11-18
Authors: J Kellogg Parsons; John P Pierce; Loki Natarajan; Vicky A Newman; Leslie Barbier; James Mohler; Cheryl L Rock; Dennis D Heath; Khurshid Guru; Michael B Jameson; Hongying Li; Hossein Mirheydar; Michael A Holmes; James Marshall Journal: Cancer Prev Res (Phila) Date: 2013-07-18